Elevance Health Inc. (ELV)

NYSE: ELV · USD

$391

+0.16 (+0.0%)· Recorded snapshot

Coverage state: Latest published research available

Market snapshot recorded 2026-08-07 02:00 UTC. Latest published research analyzed 2026-05-13 · stale · sources unverified. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate a fresh ELV analysis

The published report stays available while a new owner-requested analysis runs.

StockMarketAgent Research · Analyzed 2026-05-13

Our latest published analysis: ELV rated Strong Buy

ELV is rated Strong Buy at $381.75 versus the reconciled fair value midpoint of $632.32, implying +65.64% upside/downside. Confidence is separately disclosed at 77/100.

Fair value (mid)

$632 / share

$411 – $854

Upside to FV

+65.6%

from $391

Confidence

77/100

Moat

9/10

Read full analysis

Market cap	$82.9B
Revenue (ttm)	201.1B
Net income (ttm)	5B
EPS (ttm)	$22.5
Shares out	216.9M
P/E (trailing)	17.4x
P/E (forward)	13.1x
Dividend	$6.88 (1.76%)
Volume	910,922
Beta	0.69
Price target	$449	+14.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 201.1B
Net income (ttm): 5B
EPS (ttm): $22.5
P/E (trailing): 17.4x
P/E (forward): 13.1x
Market cap: $82.9B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	—	$156.60B	$171.34B	$176.81B	$199.13B	+6.2%
Gross profit	—	—	—	—	—	—
Operating income	—	—	—	—	—	—
Net income	—	$5.89B	$5.99B	$5.98B	$5.66B	-1.0%
EPS (diluted)	—	$24.81	$25.22	$25.68	$25.21	+0.4%
EBITDA	—	—	—	—	—	—
R&D	—	—	—	—	—	—
SG&A	$15.91B	$17.69B	—	—	—	+2.7%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	4.6T	35.8x	9.8x	101.6%	+6.1%	+54.6%	Sell
ABNB	Airbnb Inc.	90B	37.2x	6.8x	16.8%	+24.4%	+16.7%	Hold
ADBE	Adobe Inc.	103.4B	14.9x	4.1x	60.7%	+11.9%	-23.2%	Strong Buy
ABBV	AbbVie Inc.	430.9B	69.6x	6.7x	17.7%	+3.7%	+26.6%	Hold
ABT	Abbott Laboratories	186.8B	34.9x	4.0x	7.5%	+3.0%	-15.5%	Strong Buy
AMGN	Amgen Inc.	218.9B	25.2x	5.7x	19.8%	+8.4%	+39.0%	Strong Buy

All ELV indicators

Market & fundamental data

Available fields

274

Groups with data

Currency

USD

Showing 274 of 274 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001156039
Company name	Elevance Health, Inc.
Country	United States
Country code	US
Cusip	036752103
Employees	97,100
Employees Change	-7,100%
Employees Change Percent	-6.81
Enterprise value	$105.7B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Healthcare Plans
Industry PE	27.52
Industry PE Fwd	15.39
Isin	US0367521038
Last refreshed	2026-08-07
Market cap	$84.9B
Market cap category	Large-Cap
Price	$391
Price currency	USD
Rev Per Employee	2,071,204.94x
Sector	Healthcare
Sector PE	48.94
Sector PE Fwd	22.07
Sic	6324
Symbol	ELV
Website	https://www.elevancehealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.85%
EV Earnings	21.3x
EV Sales Forward	0.54x
EV/EBIT	21.55x
EV/EBITDA	15.97x
EV/FCF	16.81x
EV/Sales	0.53x
FCF yield	7.41%
Forward P/E	14.45x
P/B ratio	1.89x
P/E ratio	17.42x
P/S ratio	0.42x
PE Ratio10 Y	16.49x
PE Ratio3 Y	16.33x
PE Ratio5 Y	17.1x
PEG ratio	3.97x
PS Forward	0.43x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.47%
EBITDA Margin	3.33%
FCF margin	3.13%
Gross margin	25.99%
Gross Profit	$52.3B
Net Income	$5B
Net Income Growth	-7.41%
Net Income Growth Q	-16.06%
Net Income Growth Years	0%
Net Income Growth3 Y	-7.69%
Net Income Growth5 Y	3.24%
Pretax Margin	2.91%
Profit Margin	2.47%
Profit Per Employee	$51,112
Profitable Quarters	$104
Profitable Years	28
ROA	3.83
Roa5y	5.41
ROCE	5.97
ROE	11.13
Roe5y	15.57
ROIC	8.46
Roic5y	11.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	13.4%
Cagr15y	14.8%
Cagr1y	44.61%
Cagr20y	9.92%
Cagr3y	-3.9%
Cagr5y	2.23%
Div CAGR10	10.31%
Div CAGR3	6.3%
Div CAGR5	9.62%
EPS Growth	-3.9
EPS Growth Q	-13.08
EPS Growth Years	0
EPS Growth3 Y	-5.08
EPS Growth5 Y	5.87
FCF Growth	17.84%
FCF Growth Q	-9.01%
FCF Growth3 Y	-15.9%
FCF Growth5 Y	1.71%
OCF Growth	15.65%
OCF Growth Q	-6.87%
OCF Growth10 Y	8.43%
OCF Growth3 Y	-14.22%
OCF Growth5 Y	1.73%
Revenue Growth	6.27x
Revenue Growth Q	1.4x
Revenue Growth Quarters	55x
Revenue Growth Years	15x
Revenue Growth3 Y	6.67x
Revenue Growth5 Y	9.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.62
Assets	$126.4B
Cash	$37.5B
Debt	$31B
Debt EBITDA	$4.69
Debt Equity	$0.69
Debt FCF	$4.94
Equity	$45B
Interest Coverage	3.41
Liabilities	$81.4B
Net Cash	$-20.8B
Net Cash By Market Cap	$-24.52
Net Debt EBITDA	$3.15
Net Debt Equity	$0.46
Net Debt FCF	$3.31
Tangible Book Value	$5.6B
Tangible Book Value Per Share	$25.65
WACC	6.95

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.52
Net Working Capital	$13.1B
Quick ratio	1.37
Working Capital	$22.9B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	3.64%
Dividend Growth	1.63%
Dividend Growth Years	14%
Dividend per share	$6.88
Dividend Years	16
Dividend Yield	1.76%
Ex Div Date	2026-09-10
Last Dividend	$1.72
Payout Frequency	Quarterly
Payout Ratio	30.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	251.64%
1Y total return	44.58%
200-day SMA	351.9
3Y total return	-11.24%
50-day SMA	396.1
50-day SMA vs 200-day SMA	50over200
5Y total return	11.65%
All Time High	567.3
All Time High Change	-31%
All Time High Date	2024-09-03
All Time Low	20.18
All Time Low Change	1,840.02%
All Time Low Date	2001-10-30
ATR	12.67
Beta	0.69
Beta1y	0.83
Beta2y	0.44
Ch YTD	11.65
High	392.7
High52	436.2
High52 Date	2026-07-14
High52ch	-10.28%
Low	386.7
Low52	273.7
Low52 Date	2025-08-06
Low52ch	43%
Ma50ch	-1.19%
Premarket Change Percent	0.07
Premarket Price	$392
Price vs 200-day SMA	11.23%
RSI	51.53
RSI Monthly	51.03
RSI Weekly	56.81
Sharpe ratio	1.11x
Sortino ratio	1.69
Total Return	5.4%
Tr YTD	12.8
Tr15y	693.22%
Tr1m	-6.34%
Tr1w	3.99%
Tr3m	6.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	22
Analyst Count Top	12
Analyst Price Target Top	$454
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$6.2
Earnings EPS Estimate Growth	-29.86
Earnings Revenue Estimate	48,591,580,224x
Earnings Revenue Estimate Growth	-1.68x
Operating Income	$7.6B
Operating margin	3.79
Price target	$449
Price Target Change	$14.74
Price Target Change Top	$15.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	216,406,077%
Float Percent	99.79%
Net Borrowing	546,000,000
Shares Insiders	0.12%
Shares Institutions	95.75%
Shares Out	216,869,290
Shares Qo Q	-1.13%
Shares Yo Y	-3.64%
Short Float	2.78%
Short Ratio	3.47
Short Shares	2.78

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$6B
Adjusted OCF	7,220,000,000
Average Volume	1,470,904.8x
Bv Per Share	207
CAPEX	$-1.2B
Ch10y	206.1
Ch15y	531.8
Ch1m	-6.34
Ch1w	3.99
Ch1y	41.6
Ch20y	424.1
Ch3m	6.05
Ch3y	-15.5
Ch5y	3.91
Ch6m	17.8
Change	0.04%
Change From Open	-0.11
Close	391.2
Days Gap	0.15
Dollar Volume	356,534,870.8
Earnings Date	2026-07-15
Earnings Time	bmo
EBIT	$4.9B
EBITDA	$6.6B
EPS	$22.47
F Score	6
FCF	$6.3B
FCF EV Yield	5.95x
FCF Per Share	$29
Financing CF	-3,530,000,000
Fiscal Year End	December
Founded	1,944
Goodwill	28,339,000,000
Graham Number	323.51239
Graham Upside	-17.34
Income Tax	$915M
Investing CF	-2,243,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-15
Last Report Date	2026-06-30
Last Split Date	2005-06-01
Last Split Type	Forward
Last10k Filing Date	2026-02-06
Lynch Fair Value	$112
Lynch Upside	-71.29
Ma150	357.7
Ma150ch	9.43%
Ma20	388.1
Ma20ch	0.85%
Net CF	1,672,000,000
Next Earnings Date	2026-10-20
Open	391.8
Optionable	Yes
P FCF Ratio	13.5
P FCF Ratio SBC	14.04
P OCF Ratio	11.37
P OCF Ratio SBC	11.76
Payment Date	2026-09-25
Position In Range	77.85
Post Close	391.4
Postmarket Change Percent	0.03
Postmarket Price	$392
Ppne	4,645,000,000
Pre Close	391.2
Price Date	2026-08-06
Price EBITDA	$12.83
Ptbv Ratio	15.26
Relative Volume	0.62x
Revenue	201,114,000,000x
SBC By Revenue	0.12x
Share Based Comp	244,000,000
Tax By Revenue	0.45x
Tax Rate	15.61%
Tr20y	562.61%
Tr6m	19.01%
Us State	Indiana
Volume	910,922

Frequently asked questions

About this ELV report

What is the latest published ELV stock rating?

Elevance Health Inc. is shown with strong buy in the latest published report, analyzed 2026-05-13. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ELV analysis?

The full latest published report, analyzed 2026-05-13, lives at /stocks/ELV/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair-value range is used for ELV?

The latest published report analyzed 2026-05-13 frames ELV around USD 411 to USD 854. This is a dated valuation range, not a live market price; check the valuation, sensitivity, and bear-case tabs before making a decision.

How often is the ELV page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-05-13). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

Elevance Health Inc. (ELV)

Coverage state: Latest published research available

Generate a fresh ELV analysis

Our latest published analysis: ELV rated Strong Buy

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ELV

Valuation

Profitability

Balance sheet

Trading

Position sizing & entry playbook

Next earnings

Sector percentile context

All ELV indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ELV

Frequently asked questions